AI News NQ Analysis

Survey on Awareness of Implantable Contact Lenses (Phakic Posterior Chamber Lenses) Among Men and Women in Their 20s-40s with Vision of 0.1 or Less

NQ Score 50/100

AI Summary (NQ-processed)

At Working Co., Ltd., the Japanese distributor of "IPCL®," an implantable contact lens approved by the Ministry of Health, Labour and Welfare in April 2025, conducted a survey on implantable contact lenses among men and women in their 20s to 40s nationwide. The survey found that over 70% of respondents were aware of the treatment, with nearly the same percentage expressing interest. The primary drivers of interest were the inconvenience and ongoing cost of glasses and traditional contact lenses, while the main deterrents were fear of surgery and safety concerns. Interest was notably higher among women in their 20s and 30s.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What company conducted the survey on implantable contact lenses?
A: Working Co., Ltd., which sells the IPCL, conducted this survey nationwide.
Q: When did IPCL receive regulatory approval in Japan?
A: It obtained regulatory approval from the Ministry of Health, Labour and Welfare in April 2025.
Q: How does IPCL correct vision according to the text?
A: It corrects myopia and astigmatism by inserting a small lens into the eye.
Q: Why is IPCL considered a highly reversible treatment compared to LASIK?
A: It does not involve shaving the cornea, meaning the lens can be removed in the future.
Q: What percentage of the survey subjects were aware of implantable contact lenses?
A: More than seventy percent, specifically 72.8 percent, of the survey subjects were aware of it.